vaccine safety datalink project

(redirected from Vaccine Safety Datalink)
Also found in: Acronyms, Wikipedia.

vaccine safety datalink project

,

VSD

A collaboration between the Centers for Disease Control and Prevention and several major managed care organizations and health insurers to assess the effects of vaccinations on public health. The VSD has studied the effects of vaccination on autism, hair loss, thrombocytopenia, and neurological development in children. Website:http://www.cdc.gov/vaccinesafety/Activities/VSD.html
References in periodicals archive ?
an assessment of computerized medical records in the Vaccine Safety Datalink.
The Vaccine Safety Datalink Project used rapid cycle analysis--a study method that compares actual vs.
Monitoring by VAERS, CISA, and the Vaccine Safety Datalink Project will con tinue, the officials said.
The Vaccine Safety Datalink project monitors immunization safety and addresses the gaps in scientific knowledge about any rare and serious events that occur following immunization.
In addition to VAERS, there also is a safety monitoring system called the Vaccine Safety Datalink Project.
The safety data came from the United States Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD), two vaccine surveillance mechanisms supported by the CDC.
Information from the eight managed care organizations participating in the Vaccine Safety Datalink (VSD) indicates that approximately 94% of MCV recipients are 11-19 years old, said Dr.
She was a key contributor to the development of rapid cycle analysis for the Centers for Disease Control and Prevention's Vaccine Safety Datalink project.
However, she noted that ongoing monitoring of spontaneous reports and other sources such as the Vaccine Safety Datalink will further contribute to HPV4's safety profile.
April 23, 2012 /PRNewswire/ -- The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine.
This study of 4-6 year olds analyzed 86,750 children aged 48-83 months from seven participating Vaccine Safety Datalink sites between January 2000 and October 2008 who received either MMRV; separately administered, same-day MMR plus varicella; or MMR or varicella vaccines alone.
Kaiser Permanente researchers used its electronic health records and Vaccine Safety Datalink data from 2000 to 2008 to assess seizures and fever visits among children aged 12-23 months following MMRV and separate MMR +V.
Full browser ?